Di Rosa AE - Search Results

1

Prevalence of acute dystonic reactions associated with neuroleptic treatment with and without anticholinergic prophylaxis.

Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Among authors: di rosa ae. Int Clin Psychopharmacol. 1993 Spring;8(1):21-4. doi: 10.1097/00004850-199300810-00003. Int Clin Psychopharmacol. 1993. PMID: 8097213

2

Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients.

Spina E, De Domenico P, Ruello C, Longobardo N, Gitto C, Ancione M, Di Rosa AE, Caputi AP. Spina E, et al. Among authors: di rosa ae. Int Clin Psychopharmacol. 1994 Winter;9(4):281-5. doi: 10.1097/00004850-199400940-00007. Int Clin Psychopharmacol. 1994. PMID: 7868850 Clinical Trial.

3

Iron status in schizophrenic patients with acute neuroleptic-induced dystonic reactions.

Spina E, Ancione M, Di Rosa AE, Artemisia A, Natoli C, Caputi AP. Spina E, et al. Among authors: di rosa ae. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Sep;18(5):891-8. doi: 10.1016/0278-5846(94)90105-8. Prog Neuropsychopharmacol Biol Psychiatry. 1994. PMID: 7972859 Clinical Trial.

4

Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects.

Spina E, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Among authors: di rosa ae. Eur J Clin Pharmacol. 1992;42(3):347-8. doi: 10.1007/BF00266363. Eur J Clin Pharmacol. 1992. PMID: 1349529 No abstract available.

5

Debrisoquine oxidation phenotype and neuroleptic-induced dystonic reactions.

Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Among authors: di rosa ae. Acta Psychiatr Scand. 1992 Nov;86(5):364-6. doi: 10.1111/j.1600-0447.1992.tb03281.x. Acta Psychiatr Scand. 1992. PMID: 1485526

6

The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study.

Zoccali R, Muscatello MR, Cedro C, Neri P, La Torre D, Spina E, Di Rosa AE, Meduri M. Zoccali R, et al. Among authors: di rosa ae. Int Clin Psychopharmacol. 2004 Mar;19(2):71-6. doi: 10.1097/00004850-200403000-00003. Int Clin Psychopharmacol. 2004. PMID: 15076014 Clinical Trial.

7

The effect of clozapine on aggressive behaviour in patients with chronic schizophrenia.

De Domenico P, Di Rosa AE, Dagostino AA, Martino G, Meduri M, Spina E. De Domenico P, et al. Among authors: di rosa ae. Int J Psychiatry Clin Pract. 1999;3(1):49-54. doi: 10.3109/13651509909024759. Int J Psychiatry Clin Pract. 1999. PMID: 24945067

8

Epidemiology and pathoetiology of neurological syndromes with hyperthermia.

Di Rosa AE, Morgante L, Spina E, Meduri M. Di Rosa AE, et al. Funct Neurol. 1995 May-Jun;10(3):111-9. Funct Neurol. 1995. PMID: 8557212 Review. No abstract available.

9

Functional hyperthermia due to central dopaminergic impairment.

Di Rosa AE, Morgante L, Coraci MA, Crisafulli A, Cacciola G, Di Stefano G, Meduri M, Di Perri R. Di Rosa AE, et al. Among authors: di stefano g, di perri r. Funct Neurol. 1988 Apr-Jun;3(2):211-5. Funct Neurol. 1988. PMID: 2900182

10

Parkinson-like side effects during prolonged treatment with flunarizine.

Di Rosa AE, Morgante L, Meduri M, Musolino R, Leggiadro N, Coraci M, Crisafulli A, Di Perri R. Di Rosa AE, et al. Among authors: di perri r. Funct Neurol. 1987 Jan-Mar;2(1):47-50. Funct Neurol. 1987. PMID: 3315874 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters